SEVERANCE AGREEMENTSeverance Agreement • November 2nd, 2011 • Pharmaceutical Product Development Inc • Services-commercial physical & biological research • North Carolina
THIS SEVERANCE AGREEMENT (the “Agreement”), made as of the 16th day of September, 2011, by and between Pharmaceutical Product Development, Inc. and its subsidiaries and affiliates (collectively, “PPD”) and Raymond H. Hill (“Employee”).
THIRTEENTH LEASE AMENDMENTLease Amendment • November 2nd, 2011 • Pharmaceutical Product Development Inc • Services-commercial physical & biological research • Wisconsin
THIS THIRTEENTH LEASE AMENDMENT (this “Thirteenth Amendment”) is made and entered into this 29th day of September 2011, by and between GREENWAY OFFICE CENTER L.L.C. (the “Landlord”) and PPD DEVELOPMENT, LP (the “Tenant”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 2nd, 2011 • Pharmaceutical Product Development Inc • Services-commercial physical & biological research • North Carolina
THIS EMPLOYMENT AGREEMENT (the “Agreement”), is made and entered into on this 16th day of September, 2011 (the “Effective Date”), by and between Pharmaceutical Product Development, Inc., a North Carolina corporation (the “Company”), with a mailing address for notice purposes of 929 North Front Street, Wilmington, North Carolina 28401, Attention: Executive Chairman of the Board, and Raymond H. Hill (“Employee”), an individual whose mailing address for notice purposes is 929 North Front Street, Wilmington, North Carolina 28401.
